ImClone Systems Incorporated and DAKO Corporation have entered into an agreement for the development of an Epidermal Growth Factor receptor (EGFr) screening kit. EGFr is a receptor associated with tumor cell growth in a number of solid tumors. The kit, to be developed by DAKO, will screen patients’ tumors for over-expression of EGFr as a Read more about ImClone And DAKO To Develop Screening Kit[…]